NEW YORK (GenomeWeb) — DxTerity Diagnostics has begun commercializing blood sample collection products and a multiplex PCR reagent kit. The Los Angeles-based company displayed its product lines, called DxCollect and DxDirect, at a press event held at the American Association for Clinical Chemistry annual meeting in Chicago last week.

At the event, Bob Terbrueggen, president and CEO of DxTerity, emphasized a unique niche for these products in the new landscape for laboratory-developed testing.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.